A Chlamydia vaccine on the horizon

For the first time, a vaccine against chlamydia has completed a clinical Phase 1 trial 

In a recent publication in "Health Europa Quarterly" Frank Follmann describes the chlamydia vaccine research program at SSI, including activities within the two international research collaborations TracVac and VacPath (a MSCA - ITN consortium funded under the EU H2020 programme). Both research collaborations have partners from across Europe.

Read the publication